Neurotoxicity of Ecstasy (MDMA): An Overview

E-ISSN： 1873-4316|11|5|460-469

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.11, Iss.5, 2010-08, pp. : 460-469

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

MDMA (Ecstasy) and human dopamine, norepinephrine, and serotonin transporters: implications for MDMA-induced neurotoxicity and treatment

By Verrico Christopher Miller Gregory Madras Bertha

Psychopharmacology, Vol. 189, Iss. 4, 2007-01 ,pp. : 489-503

Springer Publishing Company

Access to resources Recommend Favorite

A bitter pill. Overview of ecstasy (MDMA, MDA) related fatalities

By Schifano Fabrizio

Psychopharmacology, Vol. 173, Iss. 3-4, 2004-05 ,pp. : 242-248

Springer Publishing Company

Access to resources Recommend Favorite

MDMA (Ecstasy) use and psychiatric problems

By Guillot Casey Berman Mitchell

Psychopharmacology, Vol. 189, Iss. 4, 2007-01 ,pp. : 575-576

Springer Publishing Company

Access to resources Recommend Favorite

Response to: Parrott AC, Buchanan T, Heffernan TM, Scholey A, Ling J, Rodgers J (2003) Parkinson’s disorder, psychomotor problems and dopaminergic neurotoxicity in recreational ecstasy/MDMA users. Psychopharmacology 167(4):449–450

By Sumnall H. Jerome L. Doblin R. Mithoefer M.

Psychopharmacology, Vol. 171, Iss. 2, 2004-01 ,pp. : 229-230

Springer Publishing Company

Access to resources Recommend Favorite

Impaired executive function in male MDMA (“ecstasy”) users

By Alting von Geusau Niels Stalenhoef Pieter Huizinga Mariette Snel Jan Ridderinkhof K.

Psychopharmacology, Vol. 175, Iss. 3, 2004-09 ,pp. : 331-341

Springer Publishing Company

Access to resources Recommend Favorite